505031-17-4Relevant academic research and scientific papers
Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity
Lange, Jos H. M.,Van Stuivenberg, Herman H.,Veerman, Willem,Wals, Henri C.,Stork, Bob,Coolen, Hein K. A. C.,McCreary, Andrew C.,Adolfs, Tiny J. P.,Kruse, Chris G.
, p. 4794 - 4798 (2007/10/03)
Novel 3,4-diarylpyrazolines 1 as potent CB1 receptor antagonists with lipophilicity lower than that of SLV319 are described. The key change is the replacement of the arylsulfonyl group in the original series by a dialkylaminosulfonyl moiety. Th
